AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.48
+0.25 (0.52%)
At close: Dec 31, 2025, 4:00 PM EST
48.00
-0.48 (-0.99%)
After-hours: Dec 31, 2025, 6:32 PM EST
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.34 billion as of December 31, 2025. Its market cap has increased by 182.95% in one year.
Market Cap
1.34B
Enterprise Value
1.44B
1-Year Change
182.95%
Ranking
Category
Stock Price
$48.48
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.34B, an increase of 334.84%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |